0001231919-25-000676.txt : 20251230 0001231919-25-000676.hdr.sgml : 20251230 20251230162227 ACCESSION NUMBER: 0001231919-25-000676 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251230 DATE AS OF CHANGE: 20251230 EFFECTIVENESS DATE: 20251230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IN8BIO, INC. CENTRAL INDEX KEY: 0001740279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-568472 FILM NUMBER: 251614544 BUSINESS ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: Incysus Therapeutics, Inc. DATE OF NAME CHANGE: 20180510 D 1 primary_doc.xml X0708 D LIVE 0001740279 IN8BIO, INC. EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY NEW YORK 10118 (646) 600-6438 DELAWARE Incysus Therapeutics, Inc. Corporation true William Ho c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Director Patrick McCall c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Alan S. Roemer c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Peter Brandt c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Emily R. Fairbairn c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Jeremy Graff c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Luba Greenwood c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Corinne Epperly c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Lawrence Lamb c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Kate Rochlin c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Biotechnology Decline to Disclose 06b false 2025-12-22 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue, 3rd Floor New York NY NEW YORK 10022 CA CALIFORNIA CT CONNECTICUT GA GEORGIA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS NY NEW YORK OR OREGON TN TENNESSEE TX TEXAS false 40239043 20119049 20119994 false 17 1207200 0 0 false IN8BIO, INC. /s/ Patrick McCall Patrick McCall Chief Financial Officer 2025-12-30